Meyhoff Medical ApS: Financial statements 2022
CVR: 40333762
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Meyhoff Medical ApS (CVR 40333762) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2022 report amounted to DKK 40,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 0
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | 0 | 40K | - |
| 2021 | - | - | 0 | 40K | - |
| 2020 | - | - | 0 | 22K | - |
| 2019 | 0 | 0 | 0 | 22K | - |
Official annual report
Keep an eye on Meyhoff Medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Meyhoff Medical ApS has published its annual report for 2021. The net result was DKK 0.
About Meyhoff Medical ApS
Meyhoff Medical ApS is a Danish company of the type Anpartsselskab based in Humlebæk, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Meyhoff Medical IVS. The management consists of Christian Sylvest Meyhoff. The board consists of Christian Sylvest Meyhoff (chair). The company is owned by Christian Sylvest Meyhoff. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 40,000.